Pergolid mesylát (Permax) jako adjuvantní léčba Parkinsonovy nemoci - prospektivní, otevřená, šstiměsíční studie

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Pergolide Mesylate (Permax) as Adjuvant Treatment of Parkinson's Disease - Prospective, Open 6-month Study
Authors	BAREŠ Martin REKTOR Ivan KAŇOVSKÝ Petr; HORTOVÁ Hana STREITOVÁ Hana KUBOVÁ Dagmar REKTOROVÁ Irena
Year of publication	2001
Type	Article in Periodical
Magazine / Source	Česká a slovenská neurologie a neurochirurgie
MU Faculty or unit	Faculty of Medicine
Citation
Field	Neurology, neurosurgery, neurosciences
Keywords	pergolide; add-on therapy; Parkinson disease
Description	Twenty-four patients with idiopathic Parkinson's disease were followed up perspectively during a 6-month period to test the incidence of undesirable effects of the preparation pergolide mesylate (Permax).
Related projects:	Plasticity of Regulatory Mechanisms of the Central Nervous Systems